Pure Global AI
European Union flag

European Union medical device registration timeline

Source-linked clocks

Notified Bodies under EU MDR 2017/745 (EU MDR) review clocks and end-to-end planning ranges, using the 4-class (I, IIa, IIb, III) classification system.

1 pathways1 of 1 clocks verifiedvalidity 5 years (CE certificate)MDSAP not acceptedreviewed 2026-08-29eur-lex.europa.eu
Class / pathwayReview clockPlanning totalWith prior approvalProvenance
Class I(Self-declaration (no notified body))
MDR Art. 52(7): non-sterile, non-measuring, non-reusable-surgical Class I devices are self-declared, so no authority or notified body reviews the file and there is no review clock
0 days6-9 monthsVerified
Review clocks exclude applicant hold time · planning totals are estimates

Planning steps and estimates; these are not regulator deadlines.

European Union Medical Device Registration Process

Step-by-step EU MDR registration process. Total estimated timeline: 6-9 months.

Step 1: Device Classification

2-4 weeks

Classify device under EU MDR Annex VIII rules. Determine conformity assessment route.

Step 2: Appoint EC REP

2-4 weeks

Foreign manufacturers must appoint an EU Authorized Representative (EC REP) for regulatory correspondence.

Step 3: Technical Documentation

3-9 months

Prepare EU MDR-compliant technical file including clinical evaluation, risk management, and biocompatibility.

Step 4: Notified Body Engagement

6-18 months

Contract with Notified Body (BSI, TUV, etc). NB capacity is limited; queue times 6-18 months.

Step 5: Conformity Assessment

6-12 months

Notified Body audits QMS (ISO 13485) and reviews technical documentation. May conduct facility audit.

Step 6: CE Marking

1-2 weeks

Upon successful assessment, affix CE mark. Register in EUDAMED. Certificate valid 5 years.

Summary: The European Union medical device registration process through Notified Bodies under EU MDR 2017/745 (EU MDR) consists of 6 main steps: Device Classification → Appoint EC REP → Technical Documentation → Notified Body Engagement → Conformity Assessment → CE Marking.
Expedited pathways
Article 59 DerogationImmediate market access

National-level exemption for public health emergencies

Eligibility: Public health emergencies only, Not for commercial reasons

Legacy Device TransitionUntil Dec 2027 (Class III) or Dec 2028 (others)

Extended deadlines for MDD-certified devices

Eligibility: Valid MDD certificate on Mar 20, 2023, No significant changes

Prior approval recognition
FDA 510(k)Clinical data can be leveraged2-4 months prep time
MDD CE MarkExtended market access during transitionUntil 2027-2028
ISO 13485QMS foundation for MDR2-4 months
Key requirements
  • EU Authorized Representative (for non-EU manufacturers)
  • Technical Documentation (Annex II & III)
  • Clinical Evaluation Report
  • Post-Market Surveillance system
  • EUDAMED registration
  • UDI implementation
  • Clinical investigation clocks (MDR Art. 70): member state notifies validation within 10 days; sponsor completes application within max 10 days (+20 extension); authorisation decision within 45 days of validation (+20 with expert extension); clock suspended during information requests (IVDR Art. 66/74 analogous)
  • Notified-body certification became time-bound only with Implementing Regulation (EU) 2026/977: before it applies on 25 Feb 2027 the review duration is purely contractual, and Art. 8(1) leaves procedures contracted before that date uncapped
  • Re-certification under Reg. (EU) 2026/977 Arts. 5-7: the notified body assesses the renewal documentation within 90 days and issues the certificate within a further 20 days, and Art. 8(3) excludes certificates expiring before 25 Nov 2027
  • Substantial changes to an approved quality system or device under Reg. (EU) 2026/977 Art. 2(3): 30 days to review the planned change, 90 days for any additional assessment, 20 days to issue the certificate supplement
  • Notified bodies must quote estimated cost and timeline up front and flag any cost increase above 10% (Reg. (EU) 2026/977 Art. 1), and from 1 Jan 2028 publish annual median duration and cost figures (Art. 4(4))
  • NB surveillance audits at least every 12 months and unannounced audits at least every 5 years
Primary regulator sources

Reviewed 2026-08-29. End-to-end totals remain planning estimates.

Keep researching this market
View the European Union resource hub →
Compare timeline across all countries →
Source-linked review clocks verified against EU MDR publications · full review 2026-08-29 · row IDs are stable — cite as registration-timeline:eu:class-i